Personalis, Inc. (PSNL): Total Assets

Annual figures by period end, from SEC filings.

$334.16M
As of 2025-12-31
$312.13M
As of 2026-06-30
+4.5%
3-year compound annual growth
+6.4%
5-year compound annual growth
$396.53M2018-12-31: $41.67M2019-12-31: $157.29M2020-12-31: $244.84M2021-12-31: $396.53M2022-12-31: $292.70M2023-12-31: $225.10M2024-12-31: $270.27M2025-12-31: $334.16M$334.16M
2018-12-31 Total Assets (USD) 2025-12-31
Period endedTotal AssetsChange YoYSource filing
2025-12-31$334.16M+23.6%2026-02-26, Balance as of period end
2024-12-31$270.27M+20.1%2026-02-26, Balance as of period end
2023-12-31$225.10M-23.1%2025-02-27, Balance as of period end
2022-12-31$292.70M-26.2%2024-02-28, Balance as of period end
2021-12-31$396.53M+62.0%2023-02-23, Balance as of period end
2020-12-31$244.84M+55.7%2022-02-24, Balance as of period end
2019-12-31$157.29M+277.5%2021-02-25, Balance as of period end
2018-12-31$41.67Mn/a2020-03-25, Balance as of period end

Total Assets at similar companies

Companies with the same SEC industry code (Services-Medical Laboratories), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

CompanyYear endedTotal AssetsChange YoY
Personalis, Inc. (PSNL)2025-12-31$334.16M+23.6%
Exagen Inc. (XGN)2025-12-31$58.02M+29.8%
Biodesix Inc (BDSX)2025-12-31$87.48M-10.0%
GRAIL, Inc. (GRAL)2025-12-31$2.92B-2.1%
CapForce Inc. (CFOR)2025-12-31$38.06M+285.8%
American Shared Hospital Services (AMS)2025-12-31$55.48M-7.8%
BillionToOne, Inc. (BLLN)2025-12-31$632.65M+109.4%
Fulgent Genetics, Inc. (FLGT)2025-12-31$1.21B-0.5%
Castle Biosciences Inc (CSTL)2025-12-31$578.56M+8.9%

Compare PSNL, XGN, BDSX, GRAL side by side · Screen every company in Services-Medical Laboratories ↗